Browse by Audience
Skip to content
Papers of the Week
Amylin analog pramlintide induces migraine-like attacks in patients.
Authors
Abstract
Migraine is a prevalent and disabling neurological disease. Its genesis is poorly understood and there remains unmet clinical need. We aimed to identify mechanisms and thus novel therapeutic targets for migraine using human models of migraine and translational models in animals, with emphasis on amylin, a close relative of calcitonin gene-related peptide (CGRP).